| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_f3685bb9940602a7da4af9c7777e0c25
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_db889de540f1640afc29772109da9a27 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K45-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K48-00 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-4422
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-277
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P35-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K31-554
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K48-00 |
| filingDate |
2009-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2012-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_b1278963eec2b923f48411a523d3f200
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_264bbb51bd478fc475169be114664516
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_a36778427a2076dfb3b971e24bbef590 |
| publicationDate |
2012-02-13-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
ES-2355882-B1 |
| titleOfInvention |
COMBINATION OF ADENOVIRUS ONCOLĂTICO AND A CALCIUM CHANNEL BLOCKER AND ITS USE FOR THE TREATMENT OF CANCER. |
| abstract |
Combination of an oncolytic adenovirus and a calcium channel blocker and its use for the treatment of cancer. # Combination comprising two components: (a) the first component is a pharmaceutical composition comprising a calcium channel blocker together with excipients or pharmaceutically acceptable carriers; and (b) the second component is a pharmaceutical composition comprising an oncolytic adenovirus together with a pharmaceutically acceptable carrier, as well as its use for separate or sequential administration for the treatment of cancer. # It also comprises the use of the calcium channel blocker in the combination as an enhancer of the oncolytic activity of adenovirus. |
| priorityDate |
2009-03-24-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |